Local application for Fungal infection

A randomized controlled clinical trial to evaluate the effect of Arka taila in the management of Dadru kushta (Dermatophytosis) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070470

Enrollment

Registered

2024-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients who will give written consent. 2)Patients who fulfil the diagnostic criteria. 3)Patients who are suffering from infection not more than 6 months. 4)Patients suffering from Tinea corporis.

Exclusion criteria

Exclusion criteria: 1)Patients associated with other type of Kushta. 2)Patient taking immunosuppressive medicine 3)Patient who is on other antifungal therapy. 4)Patient with a previous allergic reaction to a specific treatment. 5)Patients who have lesions with secondary infections like eczematisation, cellulitis etc. 6)Patients with any other systemic disorder.

Design outcomes

Primary

Measure	Time frame
To check the parameters and assess the symptoms 1)itching 2)circular lesion To assess the efficacy of drug Arka tailaTimepoint: At Day 0 , Day 8, Day 15, Day 22, Day 32, Day 42	—

Secondary

Measure	Time frame
to check the parameters and assess the symptoms 1)Raga 2)Pidaka 3)Daha 4)Rookshata Timepoint: 42 days	—

Countries

India

Contacts

Public ContactDr Nalina D S

Alvas Ayuveda Medical college

mdalvasayu@gmail.com8921385332

Outcome results